INTERFERON ALFA-2B

Search structure
Trade Names:
Synonyms:
Status: Approved (1986)
Entry Type: Protein
Molecule Category: UNKNOWN
ATC: L03AB05
UNII: 43K1W2T1M6

Pharmacology

Action Mechanism of Action Reference
AGONIST Interferon alpha/beta receptor agonist PubMed DailyMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Hepatitis B, Chronic 4 D019694 ClinicalTrials
Condylomata Acuminata 4 D003218 FDA
Leukemia, Hairy Cell 4 D007943 FDA
Lymphoma, Follicular 4 D008224 FDA
Hepatitis C, Chronic 4 D019698 FDA
Melanoma 4 D008545 ClinicalTrials
Melanoma 4 D008545 ClinicalTrials
Hepatitis B, Chronic 4 D019694 ClinicalTrials
Sarcoma, Kaposi 4 D012514 FDA
Neoplasm Metastasis 3 D009362 ClinicalTrials
HIV Infections 3 D015658 ClinicalTrials
Multiple Myeloma 3 D009101 ClinicalTrials
Liver Cirrhosis 3 D008103 ClinicalTrials
Carcinoma, Hepatocellular 3 D006528 ClinicalTrials
Hepatitis C 3 D006526 ClinicalTrials
Carcinoid Tumor 3 D002276 ClinicalTrials
Neoplasms 2 D009369 ClinicalTrials
Neoplasms 2 D009369 ClinicalTrials
Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 D015464 ClinicalTrials
Carcinoma, Renal Cell 2 D002292 ClinicalTrials
Carcinoma, Renal Cell 2 D002292 ClinicalTrials
Pancreatic Neoplasms 2 D010190 ClinicalTrials
Prostatic Neoplasms 2 D011471 ClinicalTrials
Kidney Neoplasms 2 D007680 ClinicalTrials
Liver Neoplasms 2 D008113 ClinicalTrials
Prostatic Neoplasms, Castration-Resistant 2 D064129 ClinicalTrials
Leukemia-Lymphoma, Adult T-Cell 2 D015459 ClinicalTrials
Papillomavirus Infections 2 D030361 ClinicalTrials
Severe Acute Respiratory Syndrome 2 D045169 ClinicalTrials
Breast Carcinoma In Situ 1 D000071960 ClinicalTrials
Breast Neoplasms 1 D001943 ClinicalTrials
Ovarian Neoplasms 1 D010051 ClinicalTrials
Hematologic Neoplasms 1 D019337 ClinicalTrials
Breast Neoplasms 1 D001943 ClinicalTrials
Leukemia 1 D007938 ClinicalTrials

Adverse Reactions

SOC By Demographic Distribution
System Organ Classification (SOC)
Relative Frequency (%)
General disorders and administration site conditions
21.39
Injury, poisoning and procedural complications
10.16
Gastrointestinal disorders
8.17
Nervous system disorders
7.33
Skin and subcutaneous tissue disorders
6.53
Investigations
5.26
Psychiatric disorders
4.42
Vascular disorders
4.16
Blood and lymphatic system disorders
3.62
Musculoskeletal and connective tissue disorders
3.57
Respiratory, thoracic and mediastinal disorders
3.14
Infections and infestations
3.04
Cardiac disorders
3.02
Hepatobiliary disorders
2.93
Metabolism and nutrition disorders
2.5
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
2.29

Cross References

Resources Reference
CAS NUMBER 98530-12-2
ChEMBL CHEMBL1201558
FDA SRS 43K1W2T1M6
PubChem 71306834
CONTENTS